NCT00030797View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

May 31, 2002

Study Completion Date

December 31, 2003

Conditions
Colorectal Cancer
Interventions
DRUG

Irinotecan 70 mg/m2

Irinotecan i.v. 70 mg/m2, day 1, 8, 15, 22, 29

DRUG

Irinotecan 240 mg/m2

Irinotecan i.v. 240 mg/m2 day 1 and day 22

Trial Locations (1)

CH-3010

Inselspital, Bern, Bern

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00030797 - Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter